| Trial registration number
|
IRCT20210510051248N1 |
Full text link
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/60668
|
First author
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mehraban Sadeghi
|
Contact
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
vcrt@skums.ac.ir
|
Registration date
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-01-22
|
Recruitment status
Last imported at : March 21, 2022, 10:14 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients with confirmed molecular test (PCR positive)
Blood oxygen saturation level SpO2 <93% in room air
Patients with moderate pulmonary involvement in radiological studies
No need for antibiotics in terms of indicator bacterial infection (PCT negative)
|
Exclusion criteria
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patient dissatisfaction with participation in the study
Need for antibiotics according to the indication of bacterial infection (PCT positive)
|
Number of arms
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahre-kord University of Medical Sciences
|
Inclusion age min
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
90
|
Countries
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Severe disease at enrollment
|
Severity scale
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
6: Severe disease at enrollment
|
Total sample size
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
90
|
primary outcome
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Erythrocyte Sedimentation rate
C-reactive protein
ferritin
|
Notes
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 2/Phase 3
|
Arms
Last imported at : Jan. 22, 2022, 2 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2128, "treatment_name": "Ceftriaxone+levofloxacin+remdesivir", "treatment_type": "Antibiotics+antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}]
|